Cargando…

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?

This paper examines whether screen-detected breast cancer confers additional prognostic benefit to the patient, over and above that expected by any shift in stage at presentation. In all, 5604 women (aged 50–70 years) diagnosed with invasive breast cancer between 1998 and 2003 were identified by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wishart, G C, Greenberg, D C, Britton, P D, Chou, P, Brown, C H, Purushotham, A D, Duffy, S W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410118/ https://www.ncbi.nlm.nih.gov/pubmed/18506175 http://dx.doi.org/10.1038/sj.bjc.6604368

Ejemplares similares

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

Radiological staging in breast cancer: which asymptomatic patients to image and how
por: Barrett, T, et al.
Publicado: (2009)

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
por: Pashayan, N, et al.
Publicado: (2009)

Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England
por: Ali, A M G, et al.
Publicado: (2011)

Incidental vs symptomatic renal tumours: Survival outcomes
por: Al-Marhoon, Mohammed S., et al.
Publicado: (2011)

Time from first presentation in primary care to treatment of symptomatic colorectal cancer: effect on disease stage and survival
por: Murchie, P, et al.
Publicado: (2014)

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)

Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?
por: Warren, R M L, et al.
Publicado: (2004)

The impact of eliminating age inequalities in stage at diagnosis on breast cancer survival for older women
por: Rutherford, M J, et al.
Publicado: (2015)

Survival Rate after Palliative Surgery Alone for Symptomatic Spinal Metastases: A Prospective Cohort Study
por: Kakutani, Kenichiro, et al.
Publicado: (2022)

Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma
por: Song, Yaqi, et al.
Publicado: (2016)

Corticosteroid injection alone vs additional physiotherapy treatment in early stage frozen shoulders
por: Kraal, Tim, et al.
Publicado: (2018)

Explaining the difference in prognosis between screen-detected and symptomatic breast cancers
por: Allgood, P C, et al.
Publicado: (2011)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
por: Curtis, Kelly K, et al.
Publicado: (2011)

Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening
por: Castleberry, A W, et al.
Publicado: (2009)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer
por: Uhlig, Johannes, et al.
Publicado: (2019)

Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma
por: Rutherford, M J, et al.
Publicado: (2015)

EHMTI-0052. Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, G, et al.
Publicado: (2014)

Symptomatic Anemia Due to Trichuriasis
por: Aponte-Pieras, Jose, et al.
Publicado: (2022)

One-stop diagnostic breast clinics: how often are breast cancers missed?
por: Britton, P, et al.
Publicado: (2009)

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer
por: Richards, M A, et al.
Publicado: (1999)

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
por: Berkowitz, Scott D., et al.
Publicado: (2022)

Symptomatic Epilepsies due to Cerebrovascular Diseases
por: Dakaj, Nazim, et al.
Publicado: (2014)

Symptomatic bradycardia due to nicotine intoxication
por: Paik, Jin Hui, et al.
Publicado: (2018)

Long-term outcomes of tracheobronchial stenosis due to tuberculosis (TSTB) in symptomatic patients: airway intervention vs. conservative management
por: Lee, Ken Cheah Hooi, et al.
Publicado: (2020)

Symptomatic hemorrhage after alteplase therapy not due to silent ischemia
por: Hill, Michael D, et al.
Publicado: (2001)

Survival of intestinal crypts after treatment by adriamycin alone or with radiation.
por: Moore, J. V., et al.
Publicado: (1980)

Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer
por: Hassett, Michael J, et al.
Publicado: (2018)

A randomised, phase II study of intetumumab, an anti-α(v)-integrin mAb, alone and with dacarbazine in stage IV melanoma
por: O'Day, S, et al.
Publicado: (2011)

Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
por: Kok, Victor C., et al.
Publicado: (2019)

Human giardiasis in Serbia: asymptomatic vs symptomatic infection
por: Nikolić, A., et al.
Publicado: (2011)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

A comparison of location of acute symptomatic vs. ‘silent’ small vessel lesions
por: Valdés Hernández, Maria del C., et al.
Publicado: (2015)

Study of Symptomatic vs. Silent Brain Infarctions on MRI in Elderly Subjects
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone
por: Ni, Kemin, et al.
Publicado: (2023)

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
por: Procopio, G, et al.
Publicado: (2011)

Improved incidence estimates from linked vs. stand-alone electronic health records
por: Millett, Elizabeth R.C., et al.
Publicado: (2016)

Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
por: Blasi, F., et al.
Publicado: (2017)

PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hdnpiirv9e52isngsjchiapp6o